Related Experiment Video

Updated: Nov 26, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.0K

Toll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications

Awgichew Shewasinad Yehualashet1

  • 1Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|December 14, 2020
PubMed

Insights

Diabetes mellitus (DM) causes high blood sugar and serious complications. Targeting toll-like receptors (TLRs), which mediate inflammation, shows promise for preventing and controlling diabetes and its associated health issues.

Area of Science:

  • Endocrinology
  • Immunology
  • Pharmacology

Background:

  • Diabetes mellitus (DM) is a chronic endocrine disorder characterized by hyperglycemia, leading to significant global morbidity and mortality.
  • Poor glycemic control in diabetic patients increases the risk of severe macrovascular and microvascular complications.
  • Identifying novel drug targets is crucial for managing diabetes and mitigating its complications.

Purpose of the Study:

  • To review the role of toll-like receptors (TLRs) as potential therapeutic targets for diabetes mellitus.
  • To explore the involvement of inflammatory pathways, specifically TLRs, in the pathogenesis of diabetes and its complications.

Main Methods:

  • Literature review of current research on TLRs and their involvement in metabolic disorders.
  • Analysis of studies investigating the link between inflammation and diabetes pathogenesis.
  • Evaluation of TLRs as potential drug targets for diabetes management.

Main Results:

  • Inflammatory cascades are increasingly recognized as key contributors to diabetes and its complications.
  • Toll-like receptors (TLRs) are implicated as significant mediators of inflammation in the context of diabetes.
  • Targeting TLRs presents a promising strategy for the prevention and control of diabetes and associated conditions.

Conclusions:

  • Toll-like receptors (TLRs) represent a promising therapeutic avenue for addressing diabetes mellitus.
  • Modulating inflammatory responses via TLRs could offer novel treatment strategies for diabetic complications.
  • Further research into TLR-targeted therapies is warranted for effective diabetes management.
Keywords:
TLRcomplicationdiabetes mellitusimmunityinflammation

More Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.7K
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

10.0K

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.5K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.1K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
614
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
15.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K